Investigation of superoxide dismutase 2, mitochondrial (sod2) and superoxide dismutase 3, extracellular (sod3) gene polymorphisms in patients exposed to environmental asbestos

Acta Medica Mediterranea

Volumn 29, Issue 2, 2013, Pages 285-290

  Gunak, Faruk ^a   Gencer, Mehmet ^a   Dilmec, Fuat ^a   Yalcin, Funda ^a   Sak, Zafer Hasanali ^a   Kose, Elif ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

Asbestos; Pleural plaques; Polymorphism; SOD2; SOD3

Indexed keywords

ASBESTOS; DNA; EXTRACELLULAR SUPEROXIDE DISMUTASE; MANGANESE SUPEROXIDE DISMUTASE;

ADULT; ALLELE; ARTICLE; ASBESTOSIS; CLINICAL ARTICLE; DNA ISOLATION; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84880004133     PISSN: 03936384     EISSN: 22839720     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39: 44- 84.
2. Toyokuni S. Mechanisms of asbestos-induced carcinogenesis. Nagoya J Med Sci. 2009; 71: 1-10.
3. Bhattacharya K, Dopp E, Kakkar P, et al. Biomarkers in risk assessment of asbestos exposure. Mutat Res. 2005; 579: 6-21.
4. Kamp DW, Weitzman SA. The molecular basis of asbestosis induced lung injury. Thorax. 1999; 54: 638-652.
5. Lehninger AL, Nelson David L, Cox Michael M. Principles of biochemistry. Worth Publishers Inc. 2nd ed. NY 1982; 46: 220.
6. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 1215.
7. Lee SJ, Choi MG, Kim DS, et al. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Metabolism. 2006; 55: 1-7.
8. Samoila OC, Carter AM, Futers ST, et al. Polymorphic variants of extracellular superoxide dismutase gene in a Romanian population with atheroma. Biochem Genet. 2008; 46: 634-643.
9. Martin RC, Ahn J, Nowell SA, et al. Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival. Breast Cancer Res. 2006; 8: 45.
10. Atoum M, Abdel-Fattah M, Nimer N, et al. Association of alanine-valine manganese superoxide dismutase gene polymorphism and microheterogeneity manganese superoxide dismutase activity in breast cancer and benign breast tissue. J Breast Cancer. 2012; 15: 157-61.
11. Petruzzelli S, Hietanen E, Bartsch H, et al. Pulmonary lipid in cigarette smokers and lung cancer patients. Chest 1990; 98: 930-935.
12. Safarian MD, Karapetian ET. Dynamics of the activity of antioxidant enzymes in the blood of patients with pulmonary tuberculosis. Probl Tuberk. 1990;8: 60-61.
13. Erel O. A new automated colorometric method for measuring total oxidant status. Clin Biochem. 2005; 38: 1103-1111.
14. Sahn SA, Willcox ML, Good JT Jr, et al. Characteristics of normal rabbit pleural fluid: physiologic and biochemical implications. Lung. 1979; 156: 63-69.
15. Alatas O, Metintas M, Colak O, et al. Erythrocyte antioxidant enzyme activities and lipid peroxidation in the lung carcinoma and malignant pleural mesothelioma. Eur Respir J. 1996; 9: (Suppl) 113S.
16. Mak JC, Leung HC, Ho SP, et al. Polymorphisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin Exp Allergy. 2006; 36: 440-447.
17. Bolann BJ, Ulvik RJ. Improvement of a direct spectrophotometric assay for routine determination of superoxide dismutase activity. Clin Chem. 1991; 37: 1993-1999.
18. Peskin AV, Koen YM, Zbarsky IB, et al. Superoxide dismutase activity in tumours. FEBS Lett. 1977; 78: 41-45.
19. Gencer M, Ceylan E, Aksoy N, et al. Association of serum reactive oxygen metabolite levels with different histopathological types of lung cancer. Respiration. 2006; 73: 520-524.
20. Neri M, Ugolini D, Dianzani I, et al. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res. 2008; 659: 126-136.
21. Franko A, Dolzan V, Arneric N, et al. Asbestosis and catalyze genetic polymorphism. Arh Hig Rada Toksikol. 2008; 59: 233-240.
22. Kelsey KT, Nelson HH, Wiencke JK, et al. The Glutathione S-Transferase theta and mu deletion polymorphisms in asbestosis. Am J Ind Med. 1997; 31: 274-279.